News

You are here:

Home
News

United States Plant Protein Business and Investment Opportunities Report 2020 & Forecast to 2027 – ResearchAndMarkets.com

October 26, 2020

DUBLIN–(BUSINESS WIRE)–The “United States Plant Protein Business and Investment Opportunities (2018-2027) Insight Series – White Space/Gap Analysis, Product Strategy, Innovation and Brand Share Analysis, Competitive Landscape, Market Size Across 50+ Segments – Updated in Q3, 2020” report has been added to ResearchAndMarkets.com’s offering. Plant protein industry is expected to continue to grow in United States…

Details

United States CBD Top Brands & Pricing Report 2020: Topicals are Increasing in the Market – ResearchAndMarkets.com

October 26, 2020

DUBLIN–(BUSINESS WIRE)–The “CBD Top Brands & Pricing Report: Topicals are Increasing in the US Market” report has been added to ResearchAndMarkets.com’s offering. If you are interested in the US market then this is the report for you. As well as gaining valuable data around brand engagement with product categories, and added and discontinued products, you’ll…

Details

CBD Top Brands & Pricing Report: Other Cannabinoids Enter the UK Market – ResearchAndMarkets.com

October 23, 2020

DUBLIN–(BUSINESS WIRE)–The “CBD Top Brands & Pricing Report: Other Cannabinoids Enter the UK Market” report has been added to ResearchAndMarkets.com’s offering. There has been a significant number of products that have been introduced in the CBD market during this third quarter of 2020, with oils and topicals continuing to take the lead. The UK market…

Details

$40+ Billion CBD Consumer Health Market – Global Outlook Report 2019-2020 & Forecast to 2027 – ResearchAndMarkets.com

October 23, 2020

DUBLIN–(BUSINESS WIRE)–The “CBD Consumer Health – Global Market Outlook (2019-2027)” report has been added to ResearchAndMarkets.com’s offering. Global CBD Consumer Health Market accounted for $7.89 billion in 2019 and is expected to reach $40.2 billion by 2027, growing at a CAGR of 22.6% during the forecast period. Growing legalization of cannabis-based CBD products, rise in…

Details

Organigram Confirms Additional $2.5 Million Investment in Hyasynth Biologicals Inc. as Biosynthesis Pioneer Completes First Milestone Linked to First Sale of Commercial Product and Announces Executive Changes

October 23, 2020

MONCTON, New Brunswick–(BUSINESS WIRE)–As an early investor in biosynthesis, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has funded an additional $2.5 million investment in Hyasynth Biologicals Inc. (“Hyasynth”), a private biotechnology company and pioneer…

Details

GrowerIQ Announces Partnership with High North Labs

October 22, 2020

TORONTO–(BUSINESS WIRE)–GrowerIQ, a seed-to-sale technology and cannabis cultivation platform provider, is excited to announce a partnership with High North Labs. This partnership will improve the testing process for clients, with seamless, system-to-system integration of lab results transmitted automatically to GrowerIQ’s digital batch record. The tie-up also includes benefits exclusively for GrowerIQ clients, including discounted testing…

Details

Walmart Sues DOJ and DEA Seeking Clarity for Pharmacists in Dispensing Prescription Opioids

October 22, 2020

BENTONVILLE, Ark.–(BUSINESS WIRE)–Walmart has sued the U.S. Department of Justice (DOJ) and the Drug Enforcement Administration (DEA), asking a federal court to clarify the roles and responsibilities of pharmacists and pharmacies under the Controlled Substances Act (CSA). Walmart Inc. v. DOJ, et al. is pending before the U.S. District Court for the Eastern District of…

Details

Goldfinch Bio Presents Clinical Data from Phase 1 Trial Supporting Advancement of GFB-887 as a Precision Medicine for Patients with Kidney Diseases

October 22, 2020

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced for the first time results from its Phase 1 clinical trial evaluating GFB-887, a first-in-class highly potent and selective inhibitor of Transient Receptor Potential Canonical Channel 5 (TRPC5), in healthy volunteers.…

Details

Sproutly Amends Maturity Date of Private Debt

October 22, 2020

VANCOUVER, British Columbia–(BUSINESS WIRE)–Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly” or the “Company”) announced today that the Company and Infusion Biosciences Inc. (“Infusion”) have entered into agreements to extend the maturity dates of both the $1 million private loan issued by Infusion to the Company on January 28, 2020 (the “January Infusion…

Details

Alnylam Presents Positive Results from ILLUMINATE-B Phase 3 Study in Pediatric Patients with Primary Hyperoxaluria Type 1 at the American Society of Nephrology Kidney Week

October 22, 2020

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today positive results from the 6-month primary analysis of the ILLUMINATE-B Phase 3 pediatric study of lumasiran, an investigational, subcutaneously administered RNAi therapeutic targeting hydroxyacid oxidase 1 (HAO1) – the gene encoding glycolate oxidase (GO) – in development for the treatment of…

Details

cloudPWR Launches New Website and Enhanced Cloud Software Capabilities for Government Agencies

October 22, 2020

SEATTLE–(BUSINESS WIRE)–cloudPWR, a leading cloud software provider for small and midsize government agencies, is pleased to announce the latest evolution of its cloud-based software platform with the launch of a new website. The software modernizes and greatly simplifies complex records requests and is in use by hundreds of public agency customers and thousands of users…

Details

Heritage Cannabis Announces Pura Vida and Purefarma Tinctures Available in British Columbia

October 22, 2020

TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce that both Pura Vida and Purefarma tinctures will be available for purchase next week in the province of British Columbia through the province’s authorized Liquor Distribution Branch (“LDB”) channels. BC Customers will soon be able to purchase Pura…

Details